Northcape Wealth Management’s CVS Health CVS Stock Holding History

Northcape Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27,139	Closed	-$1.6M	–	131
2024 Q2	$1.6M	Sell	27,139 -727	-3%	-$45.5K	0.58%	58
2024 Q1	$2.22M	Sell	27,866 -531	-2%	-$40.6K	0.81%	44
2023 Q4	$2.24M	Sell	28,397 -999	-3%	-$71.1K	0.81%	46
2023 Q3	$2.05M	Sell	29,396 -301	-1%	-$21.3K	0.79%	47
2023 Q2	$2.05M	Buy	29,697 +3,570	+14%	+$254K	0.74%	47
2023 Q1	$1.94M	Buy	26,127 +5,643	+28%	+$473K	0.7%	51
2022 Q4	$1.91M	Sell	20,484 -8,523	-29%	-$822K	1.07%	42
2022 Q3	$2.77M	Sell	29,007 -916	-3%	-$90.7K	0.98%	34
2022 Q2	$2.77M	Sell	29,923 -254	-0.8%	-$24.8K	1.06%	27
2022 Q1	$3.05M	Sell	30,177 -57	-0.2%	-$5.99K	0.89%	36
2021 Q4	$3.12M	Buy	+30,234	New	+$2.79M	1.05%	30

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northcape Wealth Management's CVS Position: Q3 2024 in Review

Northcape Wealth Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 27,139 shares — an estimated $1.6M sold.

Northcape Wealth Management first reported a position in CVS in Q4 2021 and held it in 11 quarters. The position peaked at $3.12M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Northcape Wealth Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Northcape Wealth Management sold 27,139 CVS Health shares in Q3 2024, an estimated $1.6M.
Northcape Wealth Management first reported a position in CVS Health in Q4 2021 and held it in 11 quarters.
Northcape Wealth Management's CVS Health position peaked at $3.12M in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Northcape Wealth Management's 13F filing for Q3 2024, filed 6 Nov 2024.